Montagu and Astorg Welcome LGT Capital Partners into Nemera
Deal News | Aug 13, 2025 | Montagu Private Equity
Montagu Private Equity, alongside Astorg, has welcomed LGT Capital Partners (LGT CP) as a new minority shareholder in Nemera, a global manufacturer of drug delivery devices. The two private equity firms continue to hold the majority of shares and aim to support Nemera's growth as the company continues its journey, leveraging LGT CP's minority stake to fuel innovation. Nemera, recognized for its complete range of drug delivery devices, operates through seven manufacturing sites spanning France, the US, Germany, Poland, and Brazil. This strategic move aligns with the firms' goals to expand Nemera's global reach, strengthen its product portfolio, and further enhance its manufacturing capabilities. The partnership with LGT CP is considered a reinforcement of confidence in Nemera's management and growth strategies, as emphasized by partners from Montagu, Astorg, and LGT CP. The lasting relationship and collaboration aim to create value and accelerate growth in the coming phases.
Sectors
- Private Equity
- Healthcare Manufacturing
Geography
- Europe – The private equity firms involved, Montagu and Astorg, are based in Europe, while LGT Capital Partners has a significant presence on the continent.
- Global – Nemera has a global footprint with operations and manufacturing facilities in Europe, the US, and South America, and serves a worldwide customer base.
Industry
- Private Equity – The article involves Montagu Private Equity, Astorg, and LGT Capital Partners, highlighting their investment strategies and operations.
- Healthcare Manufacturing – Nemera operates in the healthcare sector, focusing on manufacturing drug delivery devices, which is central to the companies' strategy and operations discussed in the article.
Financials
- Not Disclosed – The financial terms of LGT Capital Partners acquiring a minority share in Nemera have not been disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Nemera | Target Company | Company | A global manufacturer of drug delivery devices, providing comprehensive solutions from design to large-scale manufacturing. |
| Montagu Private Equity | Majority Shareholder | Company | A mid-market private equity firm focused on growth and strategic development in various sectors, including healthcare. |
| Astorg | Majority Shareholder | Company | A pan-European private equity firm with investments in healthcare, providing strategic guidance and capital. |
| LGT Capital Partners | Minority Shareholder | Company | A global specialist in alternative investing, providing investments and strategic support across various markets. |
| Morgan Stanley | Financial Advisor | Company | Financial advisor to Astorg and Montagu on this transaction. |
| Weil Gotshal & Manges | Legal Advisor | Company | Provided legal advisory services to Astorg and Montagu. |
| Heloise Pujolle | Partner at Montagu | Person | Partner at Montagu, overseeing and commenting on the strategic partnership. |
| Nicolas Marien | Partner at Astorg | Person | Partner at Astorg, providing insights on the growth and strategic developments at Nemera. |
| Andreas Hellmann | Partner at LGT Capital Partners | Person | Partner at LGT CP, emphasizing the strategic importance of the investment in Nemera. |